Tag: CT-868

Tag Visualization: Top 50 related tags by occurrence

Recent Related Articles to CT-868

Roche targets obesity market with early positive trial data

Added to Collection on: 2024-05-16 14:42:15

Tags for this article:

PEPTIDE THERAPEUTICS
Peptide hormones
GLP-1 receptor agonist
CT-868
Novo Nordisk
Glucagon-like peptide-1
Tirzepatide
Eli Lilly and Company
Obesity
Cagrilintide/semaglutide
Semaglutide

Click the tags to see associated articles and topics

View Article Details
Roche targets obesity market with early positive trial data - Pharmaceutical Technology

Added to Collection on: 2024-05-16 14:40:06

Tags for this article:

PEPTIDE THERAPEUTICS
Peptide hormones
GLP-1 receptor agonist
CT-868
Glucagon-like peptide-1
Novo Nordisk
Tirzepatide
Roche
Eli Lilly and Company

Click the tags to see associated articles and topics

View Article Details
Novo Nordisk, Lilly Slide on Roche's Obesity Drug Study Data - Yahoo Finance

Added to Collection on: 2024-07-18 19:16:31

Tags for this article:

PEPTIDE THERAPEUTICS
Peptide hormones
Novo Nordisk
Semaglutide
Eli Lilly and Company
Obesity
Roche
Anti-obesity medication
CT-868
Insulin
Weight loss

Click the tags to see associated articles and topics

View Article Details
Lilly shares slide 7% after Roche announces obesity pill test results - Indianapolis Business Journal

Added to Collection on: 2024-07-18 16:53:58

Tags for this article:

PEPTIDE THERAPEUTICS
Peptide hormones
Eli Lilly and Company
Research and development in the United States
Semaglutide
Tirzepatide
Novo Nordisk
Roche
CT-868
Weight loss
Anti-obesity medication
Dulaglutide
Eli Lilly and Co

Click the tags to see associated articles and topics

View Article Details